ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An Immune-Related Long Noncoding RNA Pair as a New Biomarker to Predict the Prognosis of Patients in Breast Cancer

Jiang, Hanwen; Sun, Jingxian; Liu, Fucong; Wu, Xincai; Wen, Zhaohui*哈尔滨医科大学; 1
Frontiers in Genetics2022-6-22DOI: 10.3389/fgene.2022.895200
5被引6阅读
引用收藏
分享

摘要

Background: Immune-related long non-coding RNAs (irlncRNAs) might remodel the tumor immune microenvironment by changing the inherent properties of tumor cells and the expression of immune genes, which have been used to predict the efficacy of immunotherapy and the prognosis of various tumors. However, the value of irlncRNAs in breast cancer (BRCA) remains unclear.Materials and Methods: Initially, transcriptome data and immune-related gene sets were downloaded from The Cancer Genome Atlas (TCGA) database. The irlncRNAs were extracted from the Immunology Database and Analysis Portal (ImmPort) database. Differently expressed irlncRNAs (DEirlncRNAs) were further identified by utilizing the limma R package. Then, univariate and multivariate Cox regression analyses were conducted to select the DEirlncRNAs associated with the prognosis of BRCA patients. In addition, the univariate and least absolute shrinkage and selection operator (LASSO) Cox regression analyses were performed to determine the DEirlncRNA pairs with the independent prediction capability of prognosis in BRCA patients. Finally, the chosen DEirlncRNA pair would be evaluated in terms of survival time, clinicopathological characteristics, tumor-infiltrating immune cells, immune checkpoints (ICs), signaling pathways, and potential small-molecule drugs.Results: A total of 21 DEirlncRNA pairs were extracted, and among them, lncRNA MIR4435-2HG and lncRNA U62317.1 were chosen to establish a risk signature that served as an independent prognostic biomarker in BRCA patients. Patients in the high-risk group had a worse prognosis than those in the low-risk group, and they also had an abundance of infiltration of CD4(+) T and CD8(+) T cells to enhance the immune response to tumor cells. Furthermore, the risk signature showed a strong correlation with ICs, signaling pathways, and potential small-molecule drugs.Conclusion: Our research revealed that the risk signature independent of specific DEirlncRNA pair expression was closely associated with the prognosis and tumor immune microenvironment in BRCA patients and had the potential to function as an independent prognostic biomarker and a predictor of immunotherapy for BRCA patients, which would provide new insights for BRCA accurate treatment.

学科与关键词

关键词
breast cancerimmune-related lncRNA pairMIR4435-2HGbiomarkerTCGA
相关
加载中…
  • A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs
    Huang, Zhijian; Xiao, Chen; Zhang, Fushou; Zhou, Zhifeng; Yu, Liang; Ye, Changsheng*; Huang, Weiwei*; Li, Nani*Frontiers in Genetics, 2021, 11: 634195.被引 8
  • Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
    Deng, Min; Lin, Jia-Bao; Zhao, Rong-Ce; Li, Shao-Hua; Lin, Wen-Ping; Zou, Jing-Wen; Wei, Wei; Guo, Rong-Ping*BMC CANCER, 2021, 21(1): 1347.被引 3
  • Identification and validation of endocrine resistance-related and immune-related long non-coding RNA (lncRNA) signatures for predicting endocrinotherapy response and prognosis in breast cancer
    Yang, Ming; Sun, Yutian; Ji, Hongfei*; Zhang, Qingyuan*Annals of Translational Medicine, 2022, 10(24): 1399.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-06-22
卷期
第 13 卷
页码
895200
DOI
10.3389/fgene.2022.895200
期刊等级
3区
成果收录
SCIE

作者

  • J

    Jiang, Hanwen (第一作者)

    1 · harbin med univ

  • S

    Sun, Jingxian

    1 · harbin med univ

查看全部 5 位作者收起作者
  • L

    Liu, Fucong

    1 · harbin med univ

  • W

    Wu, Xincai

    1 · harbin med univ

  • W

    Wen, Zhaohui (通讯)

    1 · harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417